Medtronic plc

MDT.BA·Buenos Aires·Healthcare
Compare
37,980.00−600.00 (−1.56%)today
At close: Oct 21, 4:56 PM ART · May be delayed up to 20 min · ARS

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close38,580.00
Open38,720.00
Day range37,960.0038,720.00
52-week range27,380.0041,500.00
Off day high−1.91%
Off 52-week high−8.48%
Volume446
Avg. volume (3M)1.02K
Market cap24.29T
EPS (TTM)11,540.74
Forward P/E—
P/E ratio (TTM)3.29
Dividend yield2.75% (1,034.62)
Beta (5Y)0.57
Shares outstanding639.57M
Short interest—
Earnings dateAug 19, 2025
Analyst target—
Profit margin13.93%

Against its peers

Compare in full ›
MDT.BA 300760.SZ EW ITGR BSX SYK
Market cap 24.29T 208.57B 50.95B 4.31B 64.51B 114.15B
P/E (TTM) 3.3 26.5 52.6 34.6 18.0 30.8
Forward P/E — 21.8 26.1 18.4 13.2 17.9
Price/book 5.1 5.1 4.8 2.5 2.6 4.8
Dividend yield 2.75% 2.49% — — — 1.16%
1-year change −0.36% −22.76% +14.90% +16.12% −56.11% −21.62%
Today −1.56% +1.20% +0.12% 0.00% −2.35% −2.23%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.

Latest news

All MDT.BA news ›
Medical Device Network·Positive

Medtronic’s next-gen pacemaker portfolio secures CE mark

All five of the pacemakers within Medtronic’s Vitalis portfolio use conduction system pacing to directly stimulate the heart’s natural electrical wiring. Medtronic’s Vitalis portfolio of next-generation pacemakers, each of which has been…

The Globe and Mail·Negative

Medtronic (MDT) Receives a Hold from Piper Sandler

In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic, with a price target of $85.00. According to TipRanks, O’Brien is an analyst with an average return of -4.3% and a 40.24% success rate.…

Defense World·Negative

Medtronic (NYSE:MDT) EVP Sells $1,000,320.00 in Stock

Here are the key news stories impacting Medtronic this week: View Our Latest Stock Report on Medtronic Medtronic plc (NYSE: MDT) is a global medical technology company that develops, manufactures and distributes devices and therapies used…

Defense World·

First Bank & Trust Buys 10,881 Shares of Medtronic PLC $MDT

Here are the key news stories impacting Medtronic this week: View Our Latest Analysis on Medtronic The company also recently announced a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Friday, September…

MedTech Dive·Positive

MiniMed completes separation from Medtronic

Medtronic exchanged all of its remaining shares of the diabetes technology spinoff. MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public in March, is now independent…

MedTech Dive·

Expect more tuck-in M&A, portfolio pruning in medtech, execs say

As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector. BOSTON — To reshape product portfolios for long-term success, medtech companies are likely to stay focused on tuck-in M&A and…

MarketBeat·Negative

Medtronic PLC $MDT Position Decreased by TD Waterhouse Canada Inc.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Friday, September 25th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 3.0%.…

From articles in the 4Search news index.

In the news

206mentions in 30 days
139with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.